Jonsson R et al. Sjögren’s syndrome—a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci. 2007a;1108:433–47.
CAS
Article
PubMed
Google Scholar
Haldorsen K et al. A five-year prospective study of fatigue in primary Sjögren’s syndrome. Arthritis Res Ther. 2011;13(5):R167.
CAS
Article
PubMed
PubMed Central
Google Scholar
Ramos-Casals M et al. Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS task force recommendations for articular cutaneous pulmonary and renal involvements. Rheumatology (Oxford). 2015;54(12):2230–8.
Google Scholar
Theander E et al. Lymphoma and other malignancies in primary Sjögren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis. 2006;65(6):796–803.
CAS
Article
PubMed
Google Scholar
Vitali C et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61(6):554–8.
CAS
Article
PubMed
PubMed Central
Google Scholar
Shiboski SC et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven expert consensus approach in the Sjögren’s international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken). 2012;64(4):475–87.
CAS
Article
Google Scholar
Ferro F et al. One year in review 2016: Sjögren’s syndrome. Clin Exp Rheumatol. 2016;34(2):161–71 .This manuscript presents an overview of the very latest literature on the pathogenesis, clinical features, and novel treatment of Sjögren’s syndrome
PubMed
Google Scholar
Hernandez-Molina G et al. Utility of the American-European consensus group and American College of Rheumatology Classification Criteria for Sjögren’s syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology (Oxford). 2015;54(3):441–8.
Article
Google Scholar
Seror R et al. Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies. Ann Rheum Dis. 2016. doi:10.1136/annrheumdis-2015-208504.
Google Scholar
Cornec D, Chiche L. Is primary Sjögren’s syndrome an orphan disease? A critical appraisal of prevalence studies in Europe. Ann Rheum Dis. 2015;74(3):e25. doi:10.1136/annrheumdis-2014-206860.
Article
PubMed
Google Scholar
Alamanos Y et al. Epidemiology of primary Sjögren’s syndrome in north-West Greece 1982-2003. Rheumatology (Oxford). 2006;45(2):187–91.
CAS
Article
Google Scholar
Göransson LG et al. The point prevalence of clinically relevant primary Sjögren’s syndrome in two Norwegian counties. Scand J Rheumatol. 2011;40(3):221–4 .This manuscript represents one of the latest studies estimating prevalence of Sjögren’s syndrome in Europe based on a large background population
Article
PubMed
Google Scholar
Maldini C et al. Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area. Arthritis Care Res (Hoboken). 2014;66(3):454–63 .This manuscript represents one of the latest studies estimating the prevalence of Sjögren’s syndrome in Europe based on a large background population
Article
Google Scholar
Kabasakal Y et al. The prevalence of Sjögren’s syndrome in adult women. Scand J Rheumatol. 2006;35(5):379–83.
CAS
Article
PubMed
Google Scholar
Trontzas PI, Andrianakos AA. Sjögren’s syndrome: a population based study of prevalence in Greece. The ESORDIG study. Ann Rheum Dis. 2005;64(8):1240–1.
CAS
Article
PubMed
PubMed Central
Google Scholar
Furness S et al. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011;(12):CD008934. doi:10.1002/14651858.CD008934.pub2.
Castro I et al. Oral dryness in Sjögren’s syndrome patients. Not just a question of water. Autoimmun Rev. 2013;12(5):567–74.
CAS
Article
PubMed
Google Scholar
Amerongen AV, Veerman EC. Saliva—the defender of the oral cavity. Oral Dis. 2002;8(1):12–22.
Article
PubMed
Google Scholar
Epstein JBDC. Villines and H.Y. Sroussi. Oral symptoms and oral function in people with Sjögren’s syndrome. Clin Exp Rheumatol. 2015;33(1):132–3.
PubMed
Google Scholar
Donaldson MJ. Epstein and D. Villines. Managing the care of patients with Sjögren syndrome and dry mouth: comorbidities medication use and dental care considerations. J Am Dent Assoc. 2014;145(12):1240–7.
Article
PubMed
Google Scholar
Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren’s syndrome. BMC Clin Pathol. 2005;5(1):4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Christensen LB et al. Dental caries and dental health behavior of patients with primary Sjögren syndrome. Acta Odontol Scand. 2001;59(3):116–20.
CAS
Article
PubMed
Google Scholar
Newbrun E. Current treatment modalities of oral problems of patients with Sjögren’s syndrome: caries prevention. Adv Dent Res. 1996;10(1):29–34.
CAS
Article
PubMed
Google Scholar
Le Gall M et al. A prospective evaluation of dental and periodontal status in patients with suspected Sjögren’s syndrome. Joint Bone Spine. 2016;83(2):235–6.
Article
PubMed
Google Scholar
Boutsi EA et al. Dental and periodontal status of Sjögren’s syndrome. J Clin Periodontol. 2000;27(4):231–5.
CAS
Article
PubMed
Google Scholar
Lugonja B et al. Periodontitis prevalence and serum antibody reactivity to periodontal bacteria in primary Sjögren’s syndrome: a pilot study. J Clin Periodontol. 2016;43(1):26–33.
CAS
Article
PubMed
Google Scholar
Antoniazzi R et al. Periodontal conditions of individuals with Sjögren’s syndrome. J Periodontol. 2009;80(3):429–35.
Article
PubMed
Google Scholar
Kuru B et al. Clinical and microbiological studies of periodontal disease in Sjögren syndrome patients. J Clin Periodontol. 2002;29(2):92–102.
CAS
Article
PubMed
Google Scholar
Ergun S et al. Oral status and Candida colonization in patients with Sjögren’s syndrome. Med Oral Patol Oral Cir Bucal. 2010;15(2):e310–5.
Article
PubMed
Google Scholar
Albrektsson TN. Donos and G. Working. Implant survival and complications. The third EAO consensus conference 2012. Clin Oral Implants Res. 2012;23(Suppl 6):63–5.
Article
PubMed
Google Scholar
Sousa V et al. A systematic review of implant outcomes in treated periodontitis patients. Clin Oral Implants Res. 2016;27(7):787–844.
Article
PubMed
Google Scholar
Candel-Marti ME et al. Dental implants in patients with oral mucosal alterations: an update. Med Oral Patol Oral Cir Bucal. 2011;16(6):e787–93.
Article
PubMed
Google Scholar
Binon P. Thirteen-year follow-up of a mandibular implant-supported fixed complete denture in a patient with Sjögren’s syndrome: a clinical report. J Prosthet Dent. 2005;94(5):409–13.
Article
PubMed
Google Scholar
Isidor F et al. Outcome of treatment with implant-retained dental prostheses in patients with Sjögren syndrome. Int J Oral Maxillofac Implants. 1999;14(5):736–43.
CAS
PubMed
Google Scholar
Payne AG, Lownie JF, Van Der Linden WJ. Implant-supported prostheses in patients with Sjögren’s syndrome: a clinical report on three patients. Int J Oral Maxillofac Implants. 1997;12(5):679–85.
CAS
PubMed
Google Scholar
Korfage A et al. Dental implants in patients with Sjögren’s syndrome. Clin Implant Dent Relat Res. 2015; Sep 24. doi:10.1111/cid.12376.
PubMed
Google Scholar
Albrecht K et al. The prevalence of dental implants and related factors in patients with Sjögren syndrome: results from a cohort study. J Rheumatol. 2016;43(7):1380–5.
Article
PubMed
Google Scholar
Reichart PA et al. Dental implants in patients with oral mucosal diseases - a systematic review. J Oral Rehabil. 2016;43(5):388–99.
CAS
Article
PubMed
Google Scholar
Caporali R et al. Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum. 2008;59(5):714–20.
Article
PubMed
Google Scholar
Skarstein K et al. Adipose tissue is prominent in salivary glands of Sjögren’s syndrome patients and appears to influence the microenvironment in these organs. Autoimmunity. 2016; May 20:1–9. doi:10.1080/08916934.2016.1183656.
Szyszko EA et al. Salivary glands of primary Sjögren’s syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther. 2011;13(1):R2.
Article
PubMed
PubMed Central
Google Scholar
Jousse-Joulin S et al. Is salivary gland ultrasonography a useful tool in Sjögren’s syndrome? A systematic review. Rheumatology (Oxford). 2016;55(5):789–800.
Article
Google Scholar
Hammenfors DS et al. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren’s syndrome. Clin Exp Rheumatol. 2015;33(1):56–62.
PubMed
Google Scholar
Carotti M et al. Ultrasonography of the salivary glands: the role of grey-scale and colour/power Doppler. Clin Exp Rheumatol. 2014;32(1 Suppl 80):S61–70.
PubMed
Google Scholar
Cornec D et al. Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome. Rheumatology (Oxford). 2014;53(9):1604–7.
Article
Google Scholar
Theander E, Mandl T. Primary Sjögren’s syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system. Arthritis Care Res (Hoboken). 2014;66(7):1102–7.
Article
Google Scholar
Delaleu N et al. Sjögren’s syndrome patients with ectopic germinal centers present with a distinct salivary proteome. Rheumatology (Oxford). 2016;55(6):1127–37.
Article
Google Scholar
Jonsson MV, Skarstein K. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren’s syndrome. J Oral Pathol Med. 2008;37(9):515–21.
Article
PubMed
Google Scholar
Manoussakis MN et al. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren’s syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum. 2007;56(12):3977–88.
CAS
Article
PubMed
Google Scholar
Sallusto F, Lanzavecchia A. Human Th17 cells in infection and autoimmunity. Microbes Infect. 2009;11(5):620–4.
CAS
Article
PubMed
Google Scholar
Alunno A et al. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren’s syndrome. Rheumatology (Oxford). 2013;52(8):1387–96.
CAS
Article
Google Scholar
Jin L et al. CD4 + CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjögren’s syndrome. Int J Clin Exp Pathol. 2014;7(5):1988–96.
CAS
PubMed
PubMed Central
Google Scholar
Jonsson MV et al. Serological implications of germinal center-like structures in primary Sjögren’s syndrome. J Rheumatol. 2007b;34(10):2044–9.
PubMed
Google Scholar
Theander E et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis. 2011;70(8):1363–8.
Article
PubMed
PubMed Central
Google Scholar
Quartuccio L et al. Anti-SSA/SSB-negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations and a lower risk of lymphoma evolution. Autoimmun Rev. 2015;14(11):1019–22.
CAS
Article
PubMed
Google Scholar
Nocturne G, Mariette X. Sjögren syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168(3):317–27.
CAS
Article
PubMed
Google Scholar
Cruz-Tapias et al. HLA and Sjögren’s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev. 2012;11(4):281–7.
CAS
Article
PubMed
Google Scholar
Bolstad AI et al. HLA markers and clinical characteristics in Caucasians with primary Sjögren’s syndrome. J Rheumatol. 2001;28(7):1554–62.
CAS
PubMed
Google Scholar
Hjelmervik TO et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis Rheum. 2005;52(5):1534–44.
CAS
Article
PubMed
Google Scholar
Emamian ES et al. Peripheral blood gene expression profiling in Sjögren’s syndrome. Genes Immun. 2009;10(4):285–96.
CAS
Article
PubMed
PubMed Central
Google Scholar
Lessard CJ et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat Genet. 2013;45(11):1284–92 .This manuscript represents one of two GWAS studies on Sjögren’s syndrome, and is an example of the usefulness of collaborative research effort to maximize power
CAS
Article
PubMed
Google Scholar
Li Y et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren’s syndrome at 7q11.23. Nat Genet. 2013;45(11):1361–5 .This manuscript represents one of two GWAS studies on Sjögren’s syndrome, and susceptiility loci for primary Sjögren’s syndrome is identified
CAS
Article
PubMed
Google Scholar
Burbelo PDK. Ambatipudi and I. Alevizos genome-wide association studies in Sjögren’s syndrome: what do the genes tell us about disease pathogenesis? Autoimmun Rev. 2014;13(7):756–61.
CAS
Article
PubMed
PubMed Central
Google Scholar
Forster R et al. A putative chemokine receptor BLR1 directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 1996;87(6):1037–47.
CAS
Article
PubMed
Google Scholar
Ansel KMRB. Harris and J.G. Cyster. CXCL13 is required for B1 cell homing natural antibody production and body cavity immunity. Immunity. 2002;16(1):67–76.
CAS
Article
PubMed
Google Scholar
Kramer JME. Klimatcheva and T.L. Rothstein. CXCL13 is elevated in Sjögren’s syndrome in mice and humans and is implicated in disease pathogenesis. J Leukoc Biol. 2013;94(5):1079–89.
CAS
Article
PubMed
PubMed Central
Google Scholar
Dejardin E et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 2002;17(4):525–35.
CAS
Article
PubMed
Google Scholar
Ruddle NH. Lymphotoxin and TNF: how it all began-a tribute to the travelers. Cytokine Growth Factor Rev. 2014;25(2):83–9.
CAS
Article
PubMed
PubMed Central
Google Scholar
Gommerman JL et al. The lymphotoxin network: orchestrating a type I interferon response to optimize adaptive immunity. Cytokine Growth Factor Rev. 2014;25(2):139–45.
CAS
Article
PubMed
PubMed Central
Google Scholar
Gatumu MK et al. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren’s syndrome in salivary glands of non-obese diabetic mice. Arthritis Res Ther. 2009;11(1):R24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hjelmervik TO et al. The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice. Arthritis Res Ther. 2007;9(5):R99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fava RA et al. LTBR-pathway in Sjögren’s syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR. Adv Exp Med Biol. 2011a;691:383–90.
CAS
Article
PubMed
Google Scholar
Fava RA et al. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren’s syndrome. Arthritis Res Ther. 2011b;13(6):R182.
CAS
Article
PubMed
PubMed Central
Google Scholar
Sharma A et al. Early BAFF receptor blockade mitigates murine Sjögren’s syndrome: concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction. Clin Immunol. 2016;164:85–94 .This manuscript adds to the previous publications exploring the role of CXCL13 in the disease pathogenesis of Sjögren’s syndrome
CAS
Article
PubMed
Google Scholar
Miceli-Richard C et al. Association of an IRF5 gene functional polymorphism with Sjögren’s syndrome. Arthritis Rheum. 2007;56(12):3989–94.
CAS
Article
PubMed
PubMed Central
Google Scholar
Altorok N et al. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren’s syndrome. Arthritis Rheumatol. 2014;66(3):731–9.
CAS
Article
PubMed
PubMed Central
Google Scholar
Konsta OD et al. Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren’s syndrome is associated with SSB gene expression anti-SSB/LA detection and lymphocyte infiltration. J Autoimmun. 2016;68:30–8.
CAS
Article
PubMed
Google Scholar
Cole MB et al. Epigenetic signatures of salivary gland inflammation in Sjögren’s syndrome. Arthritis Rheumatol. 2016. doi:10.1002/art.39792.
Google Scholar
Imgenberg-Kreuz J et al. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren’s syndrome reveals regulatory effects at interferon-induced genes. Ann Rheum Dis. 2016. doi:10.1136/annrheumdis-2015-208659 .This manuscript presents a DNA methylation analysis in Sjögren’s syndrome, and is an example of studies on autoimmune disesases in the epigenetic era
PubMed
PubMed Central
Google Scholar
Rönnblom L, Eloranta ML. The interferon signature in autoimmune diseases. Curr Opin Rheumatol. 2013;25(2):248–53.
Article
CAS
PubMed
Google Scholar
Båve U et al. Activation of the type I interferon system in primary Sjögren’s syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 2005;52(4):1185–95.
Article
CAS
PubMed
Google Scholar
Brkic Z et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren’s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis. 2013;72(5):728–35.
CAS
Article
PubMed
Google Scholar
Nezos A et al. Type I and II interferon signatures in Sjögren’s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjögren’s related lymphomagenesis. J Autoimmun. 2015;63:47–58.
CAS
Article
PubMed
PubMed Central
Google Scholar
Youinou et al. Viruses contribute to the development of Sjögren’s syndrome. Clin Exp Immunol. 2005;141(1):19–20.
CAS
Article
PubMed
PubMed Central
Google Scholar
Nakamura H, Kawakami A. What is the evidence for Sjögren’s syndrome being triggered by viral infection? Subplot: infections that cause clinical features of Sjögren’s syndrome. Curr Opin Rheumatol. 2016;28(4):390–7.
Article
PubMed
Google Scholar
Kuo CF et al. Familial risk of Sjögren’s syndrome and co-aggregation of autoimmune diseases in affected families: a Nationwide population study. Arthritis Rheumatol. 2015;67(7):1904–12.
Article
PubMed
PubMed Central
Google Scholar
Cartee DL et al. Sjögren’s syndrome: oral manifestations and treatment a dental perspective. J Dent Hyg. 2015;89(6):365–71.
PubMed
Google Scholar
Ramos-Casals M et al. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452–60.
CAS
Article
PubMed
Google Scholar
Zero DT et al. Clinical practice guidelines for oral management of Sjögren disease: dental caries prevention. J Am Dent Assoc. 2016;147(4):295–305.
Article
PubMed
Google Scholar
Suarez-Durall H, Mulligan R. Dry mouth: a critical topic for older adult patients. J Prosthodont Res. 2015;59(1):6–19.
Article
PubMed
Google Scholar
Furness S et al. Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev. 2013;(9):CD009603. doi:10.1002/14651858.CD009603.pub3.
Turner MD. Hyposalivation and xerostomia: etiology complications and medical management. Dent Clin N Am. 2016;60(2):435–43.
Article
PubMed
Google Scholar
Gil-Montoya JA et al. Treatment of xerostomia and hyposalivation in the elderly: a systematic review. Med Oral Patol Oral Cir Bucal. 2016;21(3):e355–66.
Article
PubMed
PubMed Central
Google Scholar
Bolstad AI, Jonsson R. Gene therapeutics in Sjögren’s syndrome. Expert Opin Biol Ther. 2005;5(6):763–72.
CAS
Article
PubMed
Google Scholar
Baum BJ et al. Advances in salivary gland gene therapy - oral and systemic implications. Expert Opin Biol Ther. 2015;15(10):1443–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kok MR et al. Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren’s syndrome. Hum Gene Ther. 2003;14(17):1605–18.
CAS
Article
PubMed
Google Scholar
Birlik M et al. Prevalence of primary Sjögren’s syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract. 2009;63(6):954–61.
CAS
Article
PubMed
Google Scholar
Anagnostopoulos I et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord. 2010;11:98. doi:10.1186/1471-2474-11-98.
Article
PubMed
PubMed Central
Google Scholar